Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a Trial of SCO-792 in Obese Patients With Type 2 Diabetes Mellitus on Metformin
jRCT1080224771Phase 2Completed
- Sponsor
- SCOHIA PHARMA, Inc.
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of Sucunamostat in type 2 diabetes mellitus (T2DM) and obesity (4 arms), sponsored by SCOHIA PHARMA, Inc. Started Jul 2019; status: completed.
02
Drugs
Sucunamostat
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on jRCT1080224771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224771.